Balyasny Asset Management L.P.

Position in IMMX — Immix Biopharma, Inc.

CIK 1218710 Chicago, IL

Position in IMMX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,301,610

+$4,234,384 QoQ

Shares Held

417,227

+3145.9% QoQ

Ownership

0.583%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#25

of 109 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,351,657,469 across 178 Biotechnology names. IMMX ranks #87 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	1,665,102	$221,008,988
2	INSM	INSMED Inc	1,326,430	$141,423,966
3	BBIO	BridgeBio Pharma, Inc.	1,230,052	$91,614,272
4	ABVX	Abivax S.A.	603,840	$80,467,718
5	VRTX	Vertex Pharmaceuticals Inc / Ma	145,005	$72,028,333
6	TNGX	Tango Therapeutics, Inc.	2,016,379	$63,032,007
7	CYTK	Cytokinetics Inc	711,676	$60,627,678
8	BMRN	Biomarin Pharmaceutical Inc	1,054,613	$60,344,955

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,301,610	417,227	+3145.9%	Shares	Sole	2026-08-14
2025-12-31	$67,226	12,854	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.